Jeffrey, S., Ballon, J., Agarwal, A. D., Woolsey, L., Savage, P. "., Xayasak, V., Syed, S., Chua-Alcala, V. S., Moradkhani, A. M., Quon, D. V., Wong, S., Chawla, N. S., Gordon, E. M., Chawla, S. P. (2025). Trial in progress: TAGGED—A phase 2 study using low dose/metronomic trabectedin, gemcitabine, and dacarbazine as 2
            <sup>nd</sup>
            /3
            <sup>rd</sup>
            /4
            <sup>th</sup>
            line therapy for advanced soft tissue sarcoma (NCT04535271).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps11589